Article citationsMore>>

Mayo, L.D., Dixon, J.E., Durden, D.L., Tonks, N.K. and Donner, D.B. (2002) PTEN Protects P53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy. Journal of Biological Chemistry, 277, 5484-5489.
https://doi.org/10.1074/jbc.m108302200

has been cited by the following article:

• TITLE: Endometrial Hyperplasia with Conservative Treatment Using the Progestin or EP Agents, Compared to Cases that Worsen during Observation

  AUTHORS: Kenji Niwa, Saki Tsurue, Kentaro Niwa, Yoh Hayasaki, Masanori Isobe, Takuji Tanaka

  KEYWORDS: Endometrial Hyperplasia, Progestin, EP, PTEN-Null

  JOURNAL NAME: Open Journal of Pathology, Vol.16 No.1, January 4, 2026

  ABSTRACT: A total of 157 patients were included in this study, comprising 147 with simple Endometrial Hyperplasia (EH) and 10 with complex EH. All patients treated cyclically with progestin or Estrogen-Progestin (EP) exhibited regression of EH after 3 or 4 treatment courses. The relapse rate in patients treated cyclically with progestin was significantly lower than that in those treated with EP for simple EH (P